Stocks our strategists [music] feel are poised to deliver positive returns are featured now in their top stock picks of the week. Hey everybody, Dave Bartoziaak here. I'm going to be joined by Kevin Cook later and we've got your top stock picks of the week.I'm going to go ahead and go first with CNX Resources ticker. You guessed it, CNX. The stock is a Zach's rank number one strong buy in the oil and gas exploration and production here in the US.A little bit more specifically, they are a lowcost provider of ...

Core Viewpoint - Franklin Covey (FC) is anticipated to report a year-over-year increase in earnings despite lower revenues for the quarter ending February 2026, with actual results being crucial for stock price movement [1][3]. Earnings Expectations - The consensus estimate indicates a quarterly loss of $0.00 per share, reflecting a year-over-year change of +100% [3][19]. - Expected revenues are projected at $58.48 million, which is a decrease of 1.9% compared to the same quarter last year [3][19]. Estimate Revisions - Over the past 30 days, the consensus EPS estimate has been revised down by 7.32% [4][19]. - The Most Accurate Estimate is lower than the Zacks Consensus Estimate, leading to an Earnings ESP of -1,700.02%, indicating a bearish outlook from analysts [12][19]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the potential deviation of actual earnings from the consensus estimate, with significant predictive power for positive readings [9][10]. - Franklin Covey's current Zacks Rank is 2 (Buy), but the negative Earnings ESP complicates predictions of an earnings beat [12][20]. Historical Performance - In the last reported quarter, Franklin Covey exceeded earnings expectations by delivering earnings of $0.07 per share against an expected $0.03, resulting in a surprise of +133.33% [13]. - The company has beaten consensus EPS estimates in three out of the last four quarters [14]. Conclusion - While Franklin Covey does not appear to be a strong candidate for an earnings beat, investors should consider other factors when making decisions regarding the stock ahead of the earnings release [17][20].

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Cintas, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Cintas is expected to report quarterly earnings of $1.23 per share, reflecting an 8.9% increase year-over-year [3]. - Revenue projections stand at $2.81 billion, indicating a 7.9% rise from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 0.09% over the last 30 days, indicating a reassessment by analysts [4]. - A positive Earnings ESP of +1.40% suggests analysts have recently become more optimistic about Cintas' earnings prospects [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - Cintas currently holds a Zacks Rank of 3, which, along with the positive Earnings ESP, suggests a likelihood of beating the consensus EPS estimate [12]. Historical Performance - Cintas has consistently beaten consensus EPS estimates, achieving this in the last four quarters [14]. - In the last reported quarter, Cintas delivered a surprise of +1.68%, with actual earnings of $1.21 per share compared to an expected $1.19 [13]. Conclusion - Cintas is positioned as a compelling candidate for an earnings beat, but investors should consider other factors influencing stock performance ahead of the earnings release [17].

Core Viewpoint - Enerpac (EPAC) is anticipated to report flat earnings of $0.39 per share for the quarter ended February 2026, with revenues expected to reach $147.8 million, reflecting a 1.6% increase from the previous year [3]. Earnings Expectations - The upcoming earnings report is scheduled for March 25, and the stock may rise if earnings exceed expectations, while a miss could lead to a decline [2]. - The consensus EPS estimate has been revised 0.63% higher in the last 30 days, indicating a slight positive sentiment among analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Enerpac is lower than the consensus estimate, resulting in an Earnings ESP of -10.26%, suggesting a bearish outlook [11]. - A positive Earnings ESP is generally a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [9]. Historical Performance - Enerpac has only beaten consensus EPS estimates once in the last four quarters, with a recent surprise of -2.70% when it reported earnings of $0.36 per share against an expectation of $0.37 [12][13]. Conclusion - Enerpac does not currently appear to be a strong candidate for an earnings beat, and investors should consider other factors when making decisions regarding this stock ahead of the earnings release [16].

Core Insights - HealthEquity reported revenue of $334.59 million for the quarter ended January 2026, reflecting a year-over-year increase of 7.3% and surpassing the Zacks Consensus Estimate by 0.52% [1] - The company's EPS for the quarter was $0.95, up from $0.69 in the same quarter last year, resulting in an EPS surprise of 7.09% compared to the consensus estimate of $0.89 [1] Financial Performance Metrics - Total HSA Assets reached $36.46 billion, exceeding the average estimate of $35.96 billion from three analysts [4] - HSA investments amounted to $18.48 billion, surpassing the average estimate of $17.66 billion [4] - Total Accounts - CDBs were reported at 7.22 million, higher than the estimated 7.12 million [4] - Total Accounts reached 17.79 million, exceeding the average estimate of 17.52 million [4] - HSA cash assets were reported at $17.98 billion, slightly below the average estimate of $18.3 billion [4] - Total Accounts - HSAs stood at 10.57 million, above the estimated 10.49 million [4] Revenue Breakdown - Revenue from Services was $127.08 million, compared to the average estimate of $123.53 million, marking a year-over-year increase of 2.3% [4] - Custodial Revenue was reported at $161.4 million, slightly below the average estimate of $163.24 million, with a year-over-year increase of 12% [4] - Interchange Revenue reached $46.11 million, exceeding the average estimate of $45.2 million, reflecting a year-over-year change of 6.1% [4] Stock Performance - HealthEquity's shares have returned +6.5% over the past month, contrasting with a -1.9% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings and revenues for KB Home in the upcoming earnings report, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - KB Home is expected to report quarterly earnings of $0.52 per share, reflecting a year-over-year decrease of 65.1% [3]. - Revenues are projected to be $1.1 billion, down 21.1% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 1.65% lower in the last 30 days, indicating a reassessment by analysts [4]. - A positive Earnings ESP of +0.28% suggests recent bullish sentiment among analysts, despite a Zacks Rank of 4 indicating a less favorable outlook [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, particularly when combined with a favorable Zacks Rank [10]. - Stocks with a positive Earnings ESP and a strong Zacks Rank have historically produced positive surprises nearly 70% of the time [10]. Historical Performance - In the last reported quarter, KB Home exceeded earnings expectations with a surprise of +7.26%, having beaten consensus EPS estimates three times over the last four quarters [13][14]. Conclusion - While KB Home does not appear to be a compelling earnings-beat candidate, investors should consider other factors influencing stock performance ahead of the earnings release [17].

分组1 - KinderCare Learning Companies, Inc. reported quarterly earnings of $0.12 per share, exceeding the Zacks Consensus Estimate of $0.08 per share, and showing an increase from $0.09 per share a year ago, resulting in an earnings surprise of +44.06% [1] - The company posted revenues of $688.14 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.27% and increasing from $646.96 million year-over-year [2] - KinderCare Learning Companies, Inc. has surpassed consensus EPS estimates three times over the last four quarters, while it has topped consensus revenue estimates only once in the same period [2] 分组2 - The stock has underperformed the market, losing about 23.8% since the beginning of the year compared to the S&P 500's decline of 1% [3] - The current consensus EPS estimate for the coming quarter is $0.20 on revenues of $678.75 million, and for the current fiscal year, it is $0.64 on revenues of $2.76 billion [7] - The Zacks Industry Rank indicates that the Schools industry is currently in the top 11% of over 250 Zacks industries, suggesting a favorable outlook for the sector [8]

Core Viewpoint - The market anticipates a year-over-year decline in FedEx's earnings despite an increase in revenues when the company reports its quarterly results for February 2026 [1] Earnings Expectations - FedEx is expected to report quarterly earnings of $4.12 per share, reflecting a year-over-year decrease of 8.7% [3] - Revenues are projected to reach $23.58 billion, which is a 6.4% increase from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 1.47% higher in the last 30 days, indicating a positive reassessment by analysts [4] - The Most Accurate Estimate for FedEx is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +2.84% [12] Earnings Surprise History - In the last reported quarter, FedEx exceeded the expected earnings of $4.07 per share by delivering $4.82, resulting in a surprise of +18.43% [13] - Over the past four quarters, FedEx has beaten consensus EPS estimates three times [14] Predictive Indicators - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [10] - Stocks with a positive Earnings ESP and a solid Zacks Rank have historically produced a positive surprise nearly 70% of the time [10]

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Monte Rosa Therapeutics due to lower revenues, with a focus on how actual results will compare to estimates [1] Earnings Expectations - Monte Rosa Therapeutics is expected to report a quarterly loss of $0.47 per share, reflecting a year-over-year change of -304.4% [3] - Revenues are projected to be $10.26 million, down 83.1% from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 6.52% higher in the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate for Monte Rosa is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +2.13% [11] Earnings Surprise Potential - A positive Earnings ESP reading suggests a likely earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [9] - Monte Rosa has a Zacks Rank of 3, indicating a potential to beat the consensus EPS estimate [11] Historical Performance - In the last reported quarter, Monte Rosa was expected to post a loss of $0.39 per share but actually reported a loss of -$0.33, resulting in a surprise of +15.38% [12] - The company has beaten consensus EPS estimates in the last four quarters [13] Industry Context - Kyntra Bio, another company in the biomedical and genetics industry, is expected to report a loss of $3.89 per share, indicating a year-over-year change of -94.5% [17] - Kyntra Bio's revenues are expected to be $1.6 million, down 49% from the previous year, with an Earnings ESP of +24.07% [18][19]

Core Viewpoint - Scholastic (SCHL) is anticipated to report a year-over-year decline in earnings due to lower revenues, with a consensus outlook indicating a quarterly loss of $0.37 per share, reflecting a significant change of -640% compared to the previous year [1][3]. Earnings Report Expectations - The earnings report is scheduled for March 19, and if the results exceed expectations, the stock may rise; conversely, a miss could lead to a decline [2]. - Management's discussion during the earnings call will be crucial in determining the sustainability of any immediate price changes and future earnings expectations [2]. Revenue and Earnings Estimates - Revenues for the upcoming quarter are projected to be $331.04 million, which is a decrease of 1.3% from the same quarter last year [3]. - The consensus EPS estimate has been revised 0.85% higher in the last 30 days, indicating a slight bullish sentiment among analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Scholastic is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +6.85% [12]. - Scholastic currently holds a Zacks Rank of 1, suggesting a strong likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Scholastic exceeded the expected earnings of $2.07 per share by delivering $2.57, resulting in a surprise of +24.15% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [14]. Conclusion - Scholastic is viewed as a compelling candidate for an earnings beat, but investors should consider other factors that may influence stock performance beyond just the earnings report [17].